Karina Cárdenas-Jaén

Karina Cárdenas-Jaén

Auto-generated profile, based on publicly available information

Karina Cárdenas-Jaén

Hospital General Universitario Doctor Balmis-ISABIAL, Alicante, Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
EDEnrique de-Madaria
Enrique de-Madaria
XMXavier Molero
Xavier Molero
LBLaia Bonjoch
Laia Bonjoch
JCJosefina Casas
Josefina Casas
KCKarina Cárdenas-Jaén
Karina Cárdenas-Jaén
DCDaniel Closa
Daniel Closa
The early prediction of the severity of acute pancreatitis still represents a challenge for clinicians. Experimental studies have revealed the generation of specific halogenated lipids, in particular oleic acid chlorohydrin, in the early stages of acute pancreatitis. We hypothesized that the levels of circulating oleic acid chlorohydrin might be a useful early prognostic biomarker in acute pancreatitis in humans. In a prospective, multicenter cohort study, plasma samples collected within 24 h after presentation in the emergency room from 59 patients with acute pancreatitis and from 9 healthy subjects were assessed for oleic acid chlorohydrin levels. Pancreatitis was mild in 30 patients, moderately severe in 16 and severe in 13. Oleic acid chlorohydrin levels within 24 h after presentation were significantly higher in patients that later progressed to moderate and severe acute pancreatitis. Using 7.49 nM as the cutoff point, oleic acid chlorohydrin distinguished mild from moderately severe-to-severe pancreatitis with high sensitivity/specificity (96.6/90.0%) and positive/negative predictive values (90.3/96.4%). Using 32.40 nM as the cutoff value sensitivity, specificity, positive and negative predictive values were all 100% for severe acute pancreatitis. It was found to be a better prognostic marker than BISAP score, hematocrit at 48 h, SIRS at admission, persistent SIRS or C-reactive protein at 48 h. Oleic acid chlorohydrin concentration in plasma is elevated in patients with acute pancreatitis on admission and correlates with a high degree with the final severity of the disease, indicating that it has potential to serve as an early prognostic marker for acute pancreatitis severity.

1 April 2021 in Gastroenterology
Verified
Journal Article
Closed access
EDEnrique de-Madaria
Enrique de-Madaria
KSKeith Siau
Keith Siau
KCKarina Cárdenas-Jaén
Karina Cárdenas-Jaén

1 October 2021 in The Journal of Pathology
Verified
Journal Article
Open access
PDF file
MCMontserrat Carrascal
Montserrat Carrascal
AAAina Areny-Balagueró
Aina Areny-Balagueró
EDEnrique de-Madaria
Enrique de-Madaria
KCKarina Cárdenas‐Jaén
Karina Cárdenas‐Jaén
GGGuillermo García‐Rayado
Guillermo García‐Rayado
DCDaniel Closa
Daniel Closa
As acute pancreatitis progresses to the severe form, a life‐threatening systemic inflammation is triggered. Although the mechanisms involved in this process are not yet well understood, it has been proposed that circulating exosomes may be involved in the progression of inflammation from the pancreas to distant organs. Here, the inflammatory capacity and protein profile of plasma exosomes obtained during the first 24 h of hospitalization of patients diagnosed with acute pancreatitis were characterized and compared with the final severity of the disease. We found that the final severity of the disease strongly correlates with the inflammatory capacity of exosomes in the early stages of acute pancreatitis. Exosomes isolated from patients with mild pancreatitis had no effect on macrophages, while exosomes isolated from patients with severe pancreatitis triggered NFκB activation, TNFα and IL1β expression, and free radical generation. To delve deeper into the mechanism involved, we performed a proteomic analysis of the different exosomes that allowed us to identify different groups of proteins whose concentration was also correlated with the clinical classification of pancreatitis. In particular, an increase in the amount of S100A8 and S100A9 carried by exosomes of severe pancreatitis suggests that the mechanism of action of exosomes is mediated by the effect of these proteins on NADPH oxidase. This enzyme is activated by S100A8/S100A9, thus generating free radicals and promoting an inflammatory response. Along these lines, we observed that inhibition of this enzyme abolished all the pro‐inflammatory effects of exosomes from severe pancreatitis. All this suggests that the systemic effects, and therefore the final severity of acute pancreatitis, are determined by the content of circulating exosomes generated in the early hours of the process. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.

1 October 2018 in United European Gastroenterology Journal
Verified
Journal Article
Open access
PDF file
GPGoran Poropat
Goran Poropat
LALivia Archibugi
Livia Archibugi
TKTaija Korpela
Taija Korpela
KCKarina Cárdenas-Jaén
Karina Cárdenas-Jaén
EDEnrique de-Madaria
Enrique de-Madaria
Gabriele CapursoGabriele Capurso
Gabriele Capurso
Background: Statins are perceived as potential etiological factors for acute pancreatitis (AP), but recent evidence suggests the opposite. Our aim was to evaluate the association between statin use and risk of AP in observational studies.Methods: Medline, Scopus, and Web of Science were searched for cohort (C) and case‐control (CC) studies evaluating statins as intervention and AP as outcome. Pooled adjusted odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated.Results: Thirteen studies (seven CC, six C) with 34,899 AP patients and 5,377,894 controls were included. Prevalence of statin use was 9.8% among AP patients and 25% among controls. Pooled adjusted OR was 1.00 (95% CI = 0.63 to 1.59) with considerable heterogeneity (I2 = 98%). CC studies were associated with increased AP risk (OR = 1.33; 95% CI = 1.20 to 1.47), unlike C studies (OR = 0.69; 95% CI = 0.37 to 1.31). No association with increased risk was found for studies from Western countries (OR = 0.90; 95% CI = 0.52 to 1.56), unlike for studies conducted in Asia (OR = 1.39; 95% CI = 1.10 to 1.75).Conclusion: Statin use is not associated with increased risk of AP. Increased risk was limited to CC studies, which are more prone to bias, while C studies showed no global effect. Further research is needed to clarify whether statin type, dosage, treatment duration or AP etiology might account for this difference.

20 August 2018 in Digestive and Liver Disease
Verified
Journal Article
Closed access
PDF file
TKTaija Korpela
Taija Korpela
KCKarina Cárdenas-Jaén
Karina Cárdenas-Jaén
LALivia Archibugi
Livia Archibugi
GPGoran Poropat
Goran Poropat
PMPatrick Maisonneuve
Patrick Maisonneuve
EDEnrique de-Madaria
Enrique de-Madaria

25 July 2020 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
KCKarina Cárdenas‐Jaén
Karina Cárdenas‐Jaén
LALivia Archibugi
Livia Archibugi
GPGoran Poropat
Goran Poropat
TKTaija Korpela
Taija Korpela
PMPatrick Maisonneuve
Patrick Maisonneuve
EDEnrique de-Madaria
Enrique de-Madaria